Women's Health, Endocrine Disruptors, Diabetes Research Will Be in Spotlight at ENDO 2016

March 22, 2016

Contact: Aaron Lohr
Chief Communications Officer
Phone: 202.971.3654
alohr@endocrine.org
Contact: Jenni Glenn Gingery
Associate Director, Communications and Media Relations
Phone: 202.971.3655
jgingery@endocrine.org

Endocrine Society announces annual meeting news conference, webcast schedule

Washington, DC - Breakthroughs and the latest research advances in women’s health, endocrine-disrupting chemicals, diabetes, obesity and bone health will be showcased in a series of press conferences at ENDO 2016, the Endocrine Society’s 98th Annual Meeting & Expo. The Society is celebrating its centennial at this year’s meeting in Boston, MA.

News Conference Schedule:

Friday, April 1

Women’s Health (9 a.m. EDT): The Society will release its new Scientific Statement on compounded bioidentical hormones used to treat menopausal symptoms and other hormone conditions during this event. The press conference also will feature research to engineer new implanted devices to treat infertility, investigate the link between polycystic ovary syndrome (PCOS) and asthma, and develop a new method to predict post-menopausal bone loss.

Endocrine-disrupting Chemicals(10 a.m. EDT): This session will examine the effect of endocrine-disrupting chemical exposure on the microbiome, attention deficit disorders in children, male fertility, and developing breast tissue and potential cancer risk.

Saturday, April 2

Diabetes (9 a.m. EDT): The press conference will delve into how the diabetes drug liraglutide affects the brain and appetite, the best breakfast proteins for people with diabetes, and the connection between thyroid disorders and Type 2 diabetes.

Obesity (11 a.m. EDT): Researchers will discuss research comparing the Paleolithic diet to a low-fat diet, early signs of childhood obesity in infants, and patterns of weight loss and gain in a large population study.

Sunday, April 3

Bone Health (9:30 a.m. EDT): Researchers will share new insights on the effects of attention-deficit hyperactivity disorder medications and anti-depressants on bone health.

Reporters may register for the meeting at: https://www.xpressreg.net/media/start.php?sc=ENDO0416. More information about media resources at ENDO 2016 is available at http://www.endocrine.org/news-room/endo-annual-meeting.

Reporters also may register to view live news conference webcasts at: www.endowebcasting.com.

Registered news media receive a badge that provides access to all meeting sessions, as well as to the Newsroom and news conferences. No one will be admitted without a valid ENDO badge.

###

Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia.